Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen-associated thromboembolism.

S Wessler1

  • 1New York University School of Medicine, NY 10016.

Annals of Epidemiology
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Estrogen therapy significantly impacts hemostasis, increasing clotting factors like fibrinogen and decreasing inhibitors such as antithrombin III, potentially raising thrombosis risk. Further research is needed to clarify these complex effects on blood coagulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanomaterial-microbe cross-talk: physicochemical principles and (patho)biological consequences.

Chemical Society reviews·2018
Same author

THROMBOEMBOLIC DISORDERS.

A listing of research in the cardiovascular field·2014
Same author

Exploiting nongenomic estrogen receptor-mediated signaling for the Development of pathway-selective Estrogen receptor ligands.

Ernst Schering Foundation symposium proceedings·2007
Same author

Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility.

Oncogene·2006
Same author

The genome of black cottonwood, Populus trichocarpa (Torr. & Gray).

Science (New York, N.Y.)·2006
Same author

Transposable element (TE) display and rapid detection of TE insertion polymorphism in the Anopheles gambiae species complex.

Insect molecular biology·2003
Same journal

What remains quantitative in quantitative intersectionality?

Annals of epidemiology·2026
Same journal

Revisiting the role of interaction effects in quantitative intersectionality research.

Annals of epidemiology·2026
Same journal

GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort.

Annals of epidemiology·2026
Same journal

Even low levels of physical activity are associated with lower all-cause mortality: A cohort study of 594,000 US adults.

Annals of epidemiology·2026
Same journal

Comment on "Distinct differences between COVID-19 vaccine refusers and vaccine hesitant in the United States: Results from a population-based survey and latent class analysis".

Annals of epidemiology·2026
Same journal

Translating caregiver-identified neighborhood features into quantitative variables for statistical analyses of effects on child health.

Annals of epidemiology·2026
See all related articles

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Endocrinology

Background:

  • The link between atherosclerosis, thrombosis, and estrogen is primarily based on epidemiological data.
  • Estrogens exert wide-ranging effects on hemostasis, with some potentially contributing to thrombus formation.

Purpose of the Study:

  • To investigate the specific effects of estrogen on coagulation and hemostasis mechanisms.
  • To clarify the impact of estrogen therapy on key hemostatic factors and inhibitors.

Main Methods:

  • Review of existing literature on estrogen's effects on hemostasis.
  • Analysis of data from platelet function tests and coagulation protein studies.
  • Examination of changes in plasma concentrations of various coagulation factors and inhibitors.

Related Experiment Videos

Main Results:

  • Consistent elevations in fibrinogen, factors II, VII, IX, X, XII, protein C, and plasminogen were observed.
  • Decreased levels of protein S and Cl esterase inhibitor were noted.
  • Significant reduction in plasma's ability to inhibit factor Xa was dose-dependently associated with estrogen use.

Conclusions:

  • Estrogen therapy significantly alters coagulation protein levels and inhibitor functions.
  • While some effects are benign, others, like reduced antithrombin activity, may increase thrombotic risk.
  • Further investigation is required to fully understand the clinical implications of these hemostatic changes.